Okafor filed his expert report on a Thursday in late May.
Sixty-two pages. The first forty were statistical analysis — adverse event rate comparisons between the raw trial data and the FDA submission, the mathematical demonstration that the algorithm modification had produced a specific and predictable change in reported cardiac event frequency. The final twenty-two pages were his expert opinion, stated with the precision of a man who had spent thirty years in pharmaceutical statistics and wasn't interested in qualification.
The modification to the adverse event classification algorithm constituted systematic falsification of clinical trial data. The resulting FDA submission materially misrepresented the drug's safety profile. There is no statistical basis on which the modified classification system could be characterized as a reasonable clinical judgment.
I read it at my desk on a Thursday morning with coffee that was getting cold.
Sixty-two pages.
It was the best expert report I'd read in four years of practice.
I sent it to Covington & Hargrove at 9 AM with a cover letter that was three sentences.
Sarah Chen was at my doorway by nine-thirty. "Okafor filed."
"Sent it across an hour ago."
She looked at me. "How are they going to respond?"
"They'll file their own expert. Probably two — one on clinical trial methodology, one on FDA regulatory interpretation. They'll argue Okafor's characterization of 'systematic falsification' exceeds his expertise and invades the province of the jury." I turned a page of the report. "They'll also argue he failed to account for alternative explanations for the algorithm modification — software maintenance, compatibility updates."
"Were there alternative explanations?"
"The version history shows the modification changed eleven specific threshold parameters, all of which produced the same directional effect: lower adverse event reporting. If this was a maintenance update, it was a very unusual one." I looked at the report. "Covington will know this. They're not stupid. The expert strategy isn't to win the scientific argument — it's to create enough uncertainty that a jury can't reach 'intentional' beyond a reasonable doubt on the criminal fraud element."
"And our response to that?"
"Timeline." I picked up the executive review agenda Dr. Rowe had mentioned — the meeting at which the adverse event data had been discussed, the meeting that preceded the algorithm modification by a specific number of weeks. "The code change happened on March 14th, 2011. The executive review meeting happened on March 8th. Six days. The agenda circulated. The CMO was present."
Sarah was quiet.
"We're not going to win this case on statistics," I said. "We're going to win it on narrative. A modified program is abstract. A chief medical officer approving a code change that buried cardiac events, six days after reviewing those events in an executive meeting — that's a story."
She nodded.
"Deposition schedule," I said. "I want the CMO in a room before Covington files their expert response. Get me a date."
Dr. Rowe came to the office on a Friday afternoon, which she'd been doing every two or three weeks since the engagement began — not because anything required her physical presence, but because she'd decided she wanted to understand the case she'd initiated rather than simply receive updates about it.
I'd come to appreciate that. She asked better questions than most clients, and better questions produced better case preparation.
"Okafor's report," she said, when she sat down.
"Filed yesterday. Covington has it."
"What happens now?"
"They file their own expert response. We depose their experts. We depose your former colleagues — the ones who can testify about the data they saw before and after the modification. We depose the CMO." I paused. "The CMO's deposition is the pivotal event in this case."
"What do you expect him to say?"
"He'll have been prepped by Covington for months. He'll claim the algorithm modification was a legitimate scientific decision made through proper review processes. He'll characterize it as an interpretive adjustment rather than a systematic change." I looked at her. "My job in that deposition is to demonstrate that no reasonable scientist, making a legitimate scientific decision, would modify eleven threshold parameters in one session, six days after a meeting in which adverse events were flagged as a regulatory concern."
She was quiet for a moment.
"He knows what he did," she said.
"Yes."
"Does that matter?"
"In a deposition, what matters is what he says and whether it's consistent with the documentary record." I picked up the version history printout — the one Marcus had found at 2 AM in May. "He modified eleven parameters. The version history has his credentials. The executive meeting agenda has his name. What he knows doesn't matter. What the documents show will."
She looked at the version history.
"I've been carrying this for a long time," she said.
"I know."
"When I first took the job at Meridian, I believed they were a good company. There are people there who are good scientists. Who didn't know what was happening at the executive level." She paused. "I don't want this to destroy the company. I want it to destroy the decision that was made."
It was the kind of distinction a less careful client wouldn't draw. A client who wanted maximum damage wouldn't care about the difference between a company and a decision. Dr. Rowe cared about patients and about scientific integrity, and she was making a principled argument about the scope of what justice required.
"That's a useful distinction for how we present the case," I said. "We're not suing Meridian for being a bad company. We're suing the specific decision chain that led to a specific falsification that produced a specific regulatory approval that now puts real patients at risk."
She nodded. "Exactly."
"The CMO is the decision. If we get a clear deposition record establishing his authorization of the modification, the company will have to choose between protecting him and protecting the institution." I looked at her. "That choice is where cases like this settle. When the individual and the corporation stop having aligned interests."
[ Argument Crusher: CMO deposition strategy. Key pressure points: (1) six-day window between meeting and modification, (2) eleven threshold changes vs. maintenance update claim, (3) career history — CMO approved FDA submission personally, (4) post-approval bonus structure. ]
"We'll be ready," I said.
Donna was reading on the couch when I got home at eight.
Not a work brief — a novel, which she did when she'd decided the evening was for something other than the job. She looked up when I came in.
"Okafor's report went out?"
"Yesterday. Covington has it."
"And?"
"Now we wait for them to file their rebuttal expert, then we depose everyone." I hung up my coat. "The CMO's deposition is in six weeks. That's the event."
She put a bookmark in the novel. "Win probability?"
I thought about it.
"58%, where it's been since the algorithm discovery. The gap between 58% and winning is jury comprehension." I went to the kitchen and started making tea I hadn't planned to make, because the activity was useful for thinking. "If I can put twelve people in a jury box and make them understand what it means that someone changed a computer program in the six days after a meeting where cardiac events were discussed — we win."
"Then that's your job," she said.
"That's always been my job."
She went back to her novel.
I stood in the kitchen with the kettle and thought about the CMO. About the executive meeting in March 2011, the agenda that Dr. Rowe had circulated, the version history that put a code change six days later. About the specific career of a man who had spent twenty years in pharmaceutical medicine and had authorized a modification that buried cardiac events for an FDA submission.
The System would have told me his psychological profile, his career incentive structure, his deposition history in prior cases. I had all of that.
What I needed to know was simpler: what does a man say when a deposition room has documented the six-day window and asks him to explain it.
I'd find out in six weeks.
The kettle boiled.
I poured two cups. Brought one to Donna without being asked.
She took it without looking up from the novel.
A LOT More chapters reign FREE upon unwrittenrealm.com.
• Normal | $8 — 15 chapters ahead
• Advanced | $11 — 20 chapters ahead
• Overlord | $19 — 25 chapters ahead, plus request a refinement (plot, character, system) on any of my novels
patreon.com/TheFinex5
▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰
― DECREE ―
More chapters reign FREE upon unwrittenrealm.com.
The throne acknowledges.
▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰